To know more about 57357 Covid-19 Clinic
Click here

Pediatric Hematology / Oncology

  • 19057
  • (202) 25351500

Education and Training

Program ID
  • Program Name: Pediatric Oncology Fellowship

  • Program Description: The program curriculum use the American Academy of Pediatrics Oncology curriculum as a guide. Training is centered primarily on CCHE with formal collaboration with DF/BC.
  • The program comprises a three track option with the express purpose of increasing the number and skill level of pediatric oncologists as well as pediatric oncology sub-specialists in Egypt and the region.

    The collaboration initiative is a joint effort between CCHF 57357 and DF/BC. The program is made up of three tracks:

    • Track 1 is a 30-month fellowship in general pediatric oncology.
    • Track 2 is a 12-month sub-specialty option for pediatric oncologists to develop expertise in a variety of pediatric oncology subspecialties.
    • Track 3 is a 12-month subspecialty focus that would be available to other non-pediatric oncology specialists to develop expertise in a variety of pediatric oncology related subspecialties.

  • Collaboration Dana-Farber Boston Children’s Cancer and Blood Disorders Center.

  • Degree /Certificate: Training Certificate from the CCHF 57357 and DF/BC.

  • Duration: Program duration is 30 months inclusive of vacation time (3 weeks per year in the first two years).

  • Location: Based at CCHE Cairo, Egypt with a rotation to DFBC in Boston MA, USA. Other affiliated hospitals or institutions in the USA may also participate in the program.

  • Mode of Delivery: On Site live training.

  • Program Content Model: Course content is set using the American Academy of Pediatric Oncology curriculum guidelines.

2020-2021 Review
  • Number of Applicants: 13 Applicant.

  • Short list: 10 Applicant.

  • Selection Process Outcome “No. of participants”: 4 Fellows.

  • Participants Scientific Activities:
    • Weekly Lectures.
    • Timed rotations and training in different diseases.
    • Study team meetings CCHE.
    • Combined clinics CCHE (50%).
    • Mortality and morbidity rounds CCHE.
    • Visiting lecturers.
    • Monthly video conferencing of difficult cases at both institutions.
    • DFBC tumor board and other appropriate joint tutorial sessions.
    • Assignments.

  • Visitors: 2020 visits From Boston team. (3 visits).

  • 1st Visit: January 2020 “Dr. Leisle Lehman”

    • Visit Duration: 2 days (8th & 9th January 2020)
    • Visit Goal:
      • Clinical rounds.
      • Research project follow-up.
      • Committee meeting.
    • Visit Outcome: revising research projects.

    2nd Visit: September 2020 “Dr. Leslie Liehman, Dr. Liliana Gomrinova & Dr. Mark Keirn”

    • Visit Duration: 4 days (20th to 23rd September 2020)

    • Visit Goals:
      • Fellow’s assessment and evaluation.
      • Follow-up update status for developing radiotherapy and infectious disease fellowship.
      • Committee meeting.
      • Fellow exam.
      • Fellow’s interview and final list acceptance.
      • Program manual update and approval.

    • Visit Outcome:
      • Policy Manual Review.
      • Candidate interview and new fellow’s selection.
      • Examine fellows 2017 & sign there certificates.
      • 2018 & 2019 6 months evaluation.

    3rd Visit: December 2020 “Dr. Mark Kierm and Dr. Liliana Joumnerova”

    • Visit Duration: 4 days (6th to 9th December 2020)

    • Visit Goals:
      • Clinical rounds.
      • Lectures.
      • Research project follow-up.
      • Follow-up update status for developing radiotherapy and infectious disease fellowship.
      • Committee meeting.
      • Program manual update and approval.

    • Visit Outcome:
      • 2020 final list updates policy manual.
      • Research projects discussion and feedback.
      • Clinical rounds and lecture was implemented as planned.
      • Orientation for new wave.
      • Committee recommendation.
      • Final outline of radiotherapy and infectious diseases fellowship.

Publication Project

Pediatric Oncology Fellowship Research Projects

Published Projects

Fellow NameClassProject titleJournal NamePublication
Impact Factor
Hisham Moneib2014Day +100 Platelet Count Predicts Survival After Allogeneic
Stem-Cell Transplantation in
Children with Hematologic Malignancies.
(Clinical Lymphoma, Myeloma and leukemia) 2019https://www.clinical-lymphoma-myeloma-
S21 52-2650(18)30585-8/fulltext
Noura Mahmoud2014Outcome of Childhood Acute
Megakaryoblastic Leukemia:
Children’s Cancer Hospital Egypt 57357 Experience.
(Clinical Lymphoma, Myeloma and leukemia) 2018https://www.clinical-lymphoma-myeloma-
S21 52-2650(18)30585-8/fulltext
Ahmed Emad2015Outcome of
Children Treated
for Infantile
Hepatic Hemangioendothelioma.
(Pediatric Hematology Oncology. 2019)
Ahmed Mahdy2015Incidence, risk factors, and outcome
of blood stream infections
during the first 100 days post‐pediatric allogeneic
and autologous hematopoietic
stem cell transplantations
(Pediatric transplantation, 2019)
ProgramsStart dateEnd dateNo. of
Year 2014
Pediatric Oncology Fellowship cohort 11-Nov-14Jul-174Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)
Year 2015
Pediatric Oncology Fellowship cohort 21-Dec-15Jul-186Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)
Year 2016
Pediatric Oncology Fellowship cohort 31-Dec-16Jul-196Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)
Year 2017
Pediatric Oncology Fellowship cohort 41-Dec-17Jul-206Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)
Year 2018
Pediatric Oncology Fellowship cohort 51-Dec-18Jul-216Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)
Year 2019
Pediatric Oncology Fellowship cohort 61-Dec-19Ongoing4Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)
Year 2020
Pediatric Oncology Fellowship cohort 71-Dec-20Ongoing4Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)

Pass Rate (No. of successful candidates/Total no of candidates): 100%

Program ID

  • Program Name: Pediatric Oncology Residency Program.

  • Program Description: Three - years Pediatric Oncology Residency program is designed to train pediatricians working in the field of pediatric oncology at CCHE in all modalities and intervention procedures. It is a structured blended training for CCHE resident to graduate a new generation of qualified and trained pediatric oncologist.

  • Degree / Certificate: Training Completion.

  • Duration: Three years.

  • Location: 57357 Children Cancer Hospital Egypt.

  • Mode of Delivery: Onsite.

  • Start/End: 1-12-2017.

  • No. of Waves: 4 Waves.

Previous years data “Program in Numbers”

  • Introduction:
  • The program is designed to equip the trainees with knowledge, skills and attitudes necessary for efficient and safe practice in the field of pediatric oncology providing high quality clinical and research training (to be a change agent) in addition to encouraging a career path in the field of pediatric oncology, The purpose of the program goes in line with the mission of 57357 hospital.

    The program consists of block rotations and supervised clinical experiences at the Children’s Cancer Hospital- Egypt 57357, inpatient, palliative care hospices care services and outpatients department of 57357.

    Our residency program will take in a cohort of 20 trainees annually, starting from January, and enroll them in a three-year training program in multiple disciplines. The program is based on three pillars; the curriculum, the rotational program, and the evaluation. Each part of the program is highlighted below.

    In order to ensure the selection of qualified trainees, our eligibility criteria necessitate that candidates have completed at least the first part of their Master’s in Pediatrics AND one-year training in general pediatrics through the university hospital or MOH teaching hospital. All our applicants are required to complete their Master’s degree in pediatrics (or pediatric oncology), prior to completing our training program, to qualify them for applying to the Boston fellowship and other postgraduate programs. This is in order to provide an incentive for career advancement. Please find the details below.

  • Scientific Activities

    1. The Curriculum: Our Scientific Content
    2. The academic curriculum of 57357 pediatric oncology (PO) residency program has been formulated through the revision of Dana Farber, European (SIOP) and Egyptian Fellowship curricula in addition to consultation with experts in the field of pediatric oncology.

      It is designed to contain 4 modules; each module has a set of mandatory courses to undertake. Highlighted below is the modular framework

      • Module I -- To be completed in 1st year
        • Orientation.
        • Basics of Oncology.
        • Hematological Malignancies.

      • Module II -- To be completed in 1st and 2nd year
        • Solid Tumors.
        • Neuro-oncology.

      • Module III -- To be completed in 2nd year
        • Supportive Care.
        • Bone Marrow Transplantation.

      • Module IV -- To be completed in 2nd year
        • Palliative Care.
        • Basic Research and Clinical Trials.

      Our curriculum objectives are to:

      1. Describe the knowledge and skills expected from the trainees upon completion of training.
      2. Describe the methods of teaching / learning (blended learning/flipped classroom).
      3. Describe the method of assessment for knowledge and skills.
      4. Describe the expected time for achievement.

      Meanwhile, trainees should pass the following mandatory, augmentative courses to ensure world-class interpersonal skills:

      • First Year
        • Advanced Life Support (ALS)
        • Infection Control
        • Basic Health Management
        • Basic Interpersonal Skills

      • Second Year
        • Intermediate soft skills (manage your team and manage your profession).
        • Patient experience – communication among health care providers.

      • Third Year
        • Advanced soft skills (manage your organization leadership and entrepreneurial ship).
        • Marketing for non-profit organization.
        • Health finance course.

    3. The Rotational Program; Our hands-on Experience

    4. Our rotational program consists of hands-on training through a series of rotational specialized pediatric oncologists who are our hospital consultants who hold M.D or board-certified. The rotational trainers will acquaint our participants with all aspects of clinical practice. The rotational program duration spans across 36 months total in multiple areas of focus. These are highlighted below.

      • Inpatient Hematological Malignancies -- 15 Months.
      • Inpatient Solid Tumors -- 6 Months.
      • Emergency Room (ER) -- 4 Months.
      • Day Care (DC) -- 3 Months.
      • Procedure Room (PR) -- 3 Months.
      • Bone Marrow Transplantation (BMT) -- 3 Months.
      • OPD -- 2 Months.

      Our trainees have to spend their training period in the following specialty to allow for the attainment of required professional readiness level.

      • Palliative Care ------ 1 Week/Year.
      • Radio-diagnosis ------ 1 Week/Year.
      • Clinical Pathology------ 1 Week/Year.
      • Pathology Lab --------- 1 Week/Year.
      • Research Department -- 1 Week/Year.

      Under supervision, the trainees will be responsible for admission of patients from the out-patient/ER. The trainees will perform all necessary procedures required for the patient.

      Also, they will share in the completion of the following documents under supervision:

      • Complete history and physical examination form.
      • Investigation of requests, (laboratory, radiology, pathology, etc.).
      • Reporting and documenting the results of the investigations.
      • Writing the plan of management after consultation approval.
      • Daily progress notes.
      • Orders of the necessary diagnostic procedures.
      • Discharge summaries.

    5. Evaluation and Monitoring of Performance
    6. In order to ensure the quality of our training, performance evaluation is conducted on a regular and continuous basis. Our evaluation form could be provided in a different attachment. The evaluation process involves all aspects of the training including the following:

      • Scientific and academic progress: conducted by end-course MCQ examination.
      • Clinical skills: Evaluated by the rotational consultant through an evaluation form.
      • Procedure skills: Assessed through a log-book.
      • Attendance and participation in scientific activities: They have to attend at least 75% of the meetings across the 3-year period. To be recorded through an attendance sheet.

2020-2021 Review

  • Pediatric Oncology Residency Program Residents Stratification

  • Residency Program Graduates Status

  • Wave No. of participants Status
    First group10Complete Residency Program
    Second group (A)4Complete Residency Program & Certified Egyptian Board PO
    Second group (B)4Complete Residency Program & Certified Egyptian Board PO
    Third group (A)4Residency program not competed (upgraded)
    (Join the Boston Fellowship Program2019)
    Third group (B)4Residency program not competed (upgraded)
    (Join the Boston Fellowship Program2020)
  • Pass Rate (No. of successful candidates/Total No. of candidates): 100